tirzepatide increase heart rate Systolic blood pressure reduction with in patients with type 2 diabetes: insights from SURPASS clinical program | Cardiovascular Diabetology Tirzepatide & Heart Rate: Cardiovascular

1 in 10 previously single users have entered a new romantic relationship since their physical transformation with GLP-1 medications

Significant changes to weight may require an adjustment to the medication regimen, which should always be guided by a healthcare provider

Toripalimab: first global approval

Absorption of vitamin B 12 is inhibited from both dietary sources and from the bile (enterohepatic circulation) and thus depletion of vitamin B 12 body stores can occur relatively quickly

Offering the same GLP-1 science as an injectable form, Oral Wegovy presents an effective, convenient solution for weight management without the need for needles

This triple-action mechanism distinguishes retatrutide from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP/GLP-1 receptor agonist), though no head-to-head clinical outcome trials comparing these agents have yet been published